• Joan Colella, Suzanne Scrofine, Bernadette Galli, Cynthia Knorr-Mulder, Glen Gejerman, John Scheuch, Vincent Lanteri, Andrew Siegel, Stuart Levey, Richard Watson, Michael Block, and Ihor Sawczuk.
• The Cancer Center, Hackensack University Medical Center, NJ, USA.
• Urol Nurs. 2006 Feb 1;26(1):57-61.

IntroductionHigh dose rate (HDR) brachytherapy is considered one of the most advanced treatment technologies currently available for treatment of localized prostate cancer. It gives the advantage of applying higher dose radiation, with greater precision, directly to the tumor while sparing healthy tissue and surrounding organs, thereby resulting in fewer side effects. In this facility, the treatment requires an overnight stay in the hospital, in a supine position, with a perineal template sutured to the perineum to prevent catheter movement or dislodgement.PurposeTo compare the effectiveness of pain management for men with prostate cancer being treated with HDR brachytherapy using a peripheral patient controlled analgesia (PCA) or patient controlled epidural analgesia (PCEA).MethodA comparative study was conducted evaluating the effectiveness of two pain management methods for men with prostate cancer receiving HDR brachytherapy. Pain assesments were conducted by scoring pain from the Foley catheter, interstitial catheter (perineal) and back (lumbosacral), using the Brief Pain Inventory Scale.ResultsPatients receiving pain management with the PCEA experienced significantly less pain.ConclusionsThese finding suggest that use of PCEA with bupivacaine and fentanyl is more effective in managing pain related to HDR brachytherapy for prostate cancer, and results in a positive patient outcome thereby improving patient satisfaction.

39 keywords...

hide…